142 related articles for article (PubMed ID: 9890157)
1. Molecular genetics of the human cytochrome P450 monooxygenase superfamily.
Smith G; Stubbins MJ; Harries LW; Wolf CR
Xenobiotica; 1998 Dec; 28(12):1129-65. PubMed ID: 9890157
[No Abstract] [Full Text] [Related]
2. CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer.
Silvestri L; Sonzogni L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Leveri M; Cividini A; Mondelli MU; Civardi E; Silini EM
Int J Cancer; 2003 Apr; 104(3):310-7. PubMed ID: 12569554
[TBL] [Abstract][Full Text] [Related]
3. Cytochromes P450 and cancer.
Kaminsky LS; Spivack SD
Mol Aspects Med; 1999; 20(1-2):70-84, 137. PubMed ID: 10575653
[No Abstract] [Full Text] [Related]
4. Significance of genetic polymorphisms in cancer susceptibility.
Hietanen E
Adv Exp Med Biol; 1999; 472():241-51. PubMed ID: 10736631
[No Abstract] [Full Text] [Related]
5. Cytochrome P450-null mice.
Buters JT; Doehmer J; Gonzalez FJ
Drug Metab Rev; 1999 May; 31(2):437-47. PubMed ID: 10335446
[No Abstract] [Full Text] [Related]
6. The human cytochrome P450 1A1 mRNA is rapidly degraded in HepG2 cells.
Lekas P; Tin KL; Lee C; Prokipcak RD
Arch Biochem Biophys; 2000 Dec; 384(2):311-8. PubMed ID: 11368318
[TBL] [Abstract][Full Text] [Related]
7. Sex differences in drug metabolism: cytochrome P-450 and uridine diphosphate glucuronosyltransferase.
Anderson GD
J Gend Specif Med; 2002; 5(1):25-33. PubMed ID: 11859684
[TBL] [Abstract][Full Text] [Related]
8. Identification of cytochrome P450s in human glioma cell line.
Vasquez HG; Strobel H
Int J Oncol; 1998 Jun; 12(6):1291-4. PubMed ID: 9592188
[TBL] [Abstract][Full Text] [Related]
9. Differences in the Epigenetic Regulation of Cytochrome P450 Genes between Human Embryonic Stem Cell-Derived Hepatocytes and Primary Hepatocytes.
Park HJ; Choi YJ; Kim JW; Chun HS; Im I; Yoon S; Han YM; Song CW; Kim H
PLoS One; 2015; 10(7):e0132992. PubMed ID: 26177506
[TBL] [Abstract][Full Text] [Related]
10. Bioavailable flavonoids: cytochrome P450-mediated metabolism of methoxyflavones.
Walle UK; Walle T
Drug Metab Dispos; 2007 Nov; 35(11):1985-9. PubMed ID: 17709371
[TBL] [Abstract][Full Text] [Related]
11. Identification and hepatic expression profiles of cytochrome P450 1-4 isozymes in common minke whales (Balaenoptera acutorostrata).
Niimi S; Kim EY; Iwata H; Watanabe MX; Yasunaga G; Fujise Y; Tanabe S
Comp Biochem Physiol B Biochem Mol Biol; 2007 Aug; 147(4):667-81. PubMed ID: 17526421
[TBL] [Abstract][Full Text] [Related]
12. Ah receptor, CYP1A1, CYP1A2 and CYP1B1 gene polymorphisms are not involved in the risk of recurrent pregnancy loss.
Saijo Y; Sata F; Yamada H; Suzuki K; Sasaki S; Kondo T; Gong YY; Kato EH; Shimada S; Morikawa M; Minakami H; Kishi R
Mol Hum Reprod; 2004 Oct; 10(10):729-33. PubMed ID: 15299091
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the substrate specificities of human liver cytochrome P450s 2C9 and 2C18: application to the design of a specific substrate of CYP 2C18.
Minoletti C; Dijols S; Dansette PM; Mansuy D
Biochemistry; 1999 Jun; 38(24):7828-36. PubMed ID: 10387023
[TBL] [Abstract][Full Text] [Related]
14. Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: catalytic activities and mutagenicity studies.
Kranendonk M; Carreira F; Theisen P; Laires A; Fisher CW; Rueff J; Estabrook RW; Vermeulen NP
Mutat Res; 1999 Apr; 441(1):73-83. PubMed ID: 10224324
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of cytochrome P450 enzymes in normal and tumor tissues from childhood rhabdomyosarcoma.
Molina-Ortiz D; Camacho-Carranza R; González-Zamora JF; Shalkow-Kalincovstein J; Cárdenas-Cardós R; Ností-Palacios R; Vences-Mejía A
PLoS One; 2014; 9(4):e93261. PubMed ID: 24699256
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population.
Murata M; Watanabe M; Yamanaka M; Kubota Y; Ito H; Nagao M; Katoh T; Kamataki T; Kawamura J; Yatani R; Shiraishi T
Cancer Lett; 2001 Apr; 165(2):171-7. PubMed ID: 11275366
[TBL] [Abstract][Full Text] [Related]
17. Modulation of rat liver cytochrome P450 by protein restriction assessed by biochemical and bacterial mutagenicity methods [corrected].
Cancino-Badías L; Reyes RE; Nosti R; Pérez I; Dorado V; Caballero S; Soria A; Camacho-Carranza R; Escobar D; Espinosa-Aguirre JJ
Mutagenesis; 2003 Jan; 18(1):95-100. PubMed ID: 12473742
[TBL] [Abstract][Full Text] [Related]
18. Differential Effects of Sunitinib on the Expression Profiles of Xenobiotic-Metabolizing Enzymes and Transporters in Rat Liver and Kidneys.
Korashy HM; Ansari MA; Maayah ZH; Imam F; Raish M; Attafi IM; Alharbi NO; Moraished BA
Basic Clin Pharmacol Toxicol; 2016 Aug; 119(2):173-83. PubMed ID: 26797788
[TBL] [Abstract][Full Text] [Related]
19. Chlorzoxazone metabolism by porcine cytochrome P450 enzymes and the effect of cytochrome b5.
Wiercinska P; Squires EJ
Drug Metab Dispos; 2010 May; 38(5):857-62. PubMed ID: 20164110
[TBL] [Abstract][Full Text] [Related]
20. Role of human cytochrome P450 (CYP) in the metabolic activation of N-alkylnitrosamines: application of genetically engineered Salmonella typhimurium YG7108 expressing each form of CYP together with human NADPH-cytochrome P450 reductase.
Fujita K; Kamataki T
Mutat Res; 2001 Nov; 483(1-2):35-41. PubMed ID: 11600130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
